March 7 (Reuters) - Cigna on Thursday announced its unit is launching a financial guarantee program to help companies and other clients manage the rising drugs expenses associated with using GLP-1 weight loss and diabetes drugs. (Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar)
Market Closed -
Other stock markets
|
Pre-market 12:00:23 | |||
347.4 USD | +0.19% | 346 | -0.39% |
05-06 | UBS Adjusts Cigna Price Target to $410 From $400, Maintains Buy Rating | MT |
05-06 | Jefferies Adjusts Price Target on Cigna to $407 From $385, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.00% | 98.67B | |
-4.42% | 463B | |
+13.10% | 124B | |
-29.20% | 39.06B | |
-4.68% | 20.18B | |
-13.50% | 3.09B | |
-21.25% | 1.3B | |
-8.56% | 432M |
- Stock Market
- Equities
- CI Stock
- News Cigna
- Cigna launches program to help clients manage rising costs due to weight loss drug boom